Quarterly report pursuant to Section 13 or 15(d)

Organization, Business (Details)

v3.21.2
Organization, Business (Details) - USD ($)
 9 Months Ended
Aug. 11, 2021
Jan. 06, 2021
Jan. 03, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
May 13, 2019
Subsidiary, Sale of Stock [Line Items]              
Common Stock, Shares, Outstanding       12,619,256   5,556,394  
Cash and Cash Equivalents, at Carrying Value       $ 11,106,927   $ 1,185,677  
Retained Earnings (Accumulated Deficit)       (116,355,777)   $ (108,338,834)  
Proceeds from Issuance of Private Placement   $ 8,000,000.0          
Proceeds from Issuance of Common Stock $ 9,800,000   $ 4,500,000 $ 17,745,207 $ 4,501,313    
Capital Units, Authorized             50,000,000
Series A Preferred Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Preferred Stock, Shares Outstanding       0   0  
Series B Preferred Stock              
Subsidiary, Sale of Stock [Line Items]              
Preferred Stock, Shares Outstanding       0   0  
Series C Preferred Stock              
Subsidiary, Sale of Stock [Line Items]              
Preferred Stock, Shares Outstanding       0   4,092  
Series C Preferred Stock | Armistice Capital, LLC [Member]              
Subsidiary, Sale of Stock [Line Items]              
Retained Earnings (Accumulated Deficit)       $ 116,356,000      
Series D Preferred Stock              
Subsidiary, Sale of Stock [Line Items]              
Preferred Stock, Shares Outstanding       46   46  
Registered direct offering              
Subsidiary, Sale of Stock [Line Items]              
Proceeds from Issuance of Private Placement $ 9,800,000